Hikma Pharmaceutical reported 368M in EBITDA for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
AstraZeneca AZN:LN 4187M 687M
Fresenius FRE:GR € 1496M 212M
Fresenius Medical Care FMS:US $ 852.14M 149.16M
Galapagos GLPG:NA € -15.63M 31.37M
GlaxoSmithKline GSK:LN 3120M 1062M
GRIFOLS GRF:SM € 329.18M 78.53M
H. Lundbeck A/S LUN:DC 1.29B 850M
Hikma Pharmaceutical HIK:LN 368M 10M
Lonza Group LONN:SW 789M 58M
Merck MRK:GR € 1630M 173M
Orion ORNBV:FH € 83M 34.6M
Recordati REC:IM € 163.05M 8.44M